Boron neutron capture therapy: Moving toward targeted cancer therapy

HR Mirzaei, A Sahebkar, R Salehi… - Journal of cancer …, 2016 - journals.lww.com
Boron neutron capture therapy (BNCT) occurs when a stable isotope, boton-10, is irradiated
with low-energy thermal neutrons to yield stripped down helium-4 nuclei and lithium-7 …

Boron neutron capture therapy for urological cancers

K Takahara, SI Miyatake, H Azuma… - International Journal of …, 2022 - Wiley Online Library
Boron neutron capture therapy is based on a nuclear reaction between the nonradioactive
isotope boron‐10 and either low‐energy thermal neutrons or high‐energy epithermal …

Synthesis and preliminary biological assessment of carborane-loaded theranostic nanoparticles to target prostate-specific membrane antigen

N Meher, K Seo, S Wang, AP Bidkar… - … applied materials & …, 2021 - ACS Publications
Boron neutron capture therapy (BNCT) is an encouraging therapeutic modality for cancer
treatment. Prostate-specific membrane antigen (PSMA) is a cell membrane protein that is …

Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes

Q Lin, KL Mao, FR Tian, JJ Yang, PP Chen, J Xu… - Cancer chemotherapy …, 2016 - Springer
Brain tumor lacks effective delivery system for treatment. Focused ultrasound (FUS) can
reversibly open BBB without impacts on normal tissues. As a potential drug carrier, cationic …

Recent advances in boron delivery agents for boron neutron capture therapy (BNCT)

S Xuan, MGH Vicente - Boron‐Based Compounds: Potential …, 2018 - Wiley Online Library
Boron neutron capture therapy (BNCT) has the potential to be used as an effective therapy
for the treatment of various tumors. Promising classes of boronated compounds, including …

The anti-proliferative effect of boron neutron capture therapy in a prostate cancer xenograft model

K Takahara, T Inamoto, K Minami, Y Yoshikawa… - PloS one, 2015 - journals.plos.org
Purpose Boron neutron capture therapy (BNCT) is a selective radiation treatment for tumors
that preferentially accumulate drugs carrying the stable boron isotope, 10B. BNCT has been …

Current perspectives on novel drug delivery systems and therapies for management of prostate cancer: An inclusive review

RR Bhosale, HV Gangadharappa, U Hani… - Current Drug …, 2017 - ingentaconnect.com
Background: Prostate cancer (PC) is a prostate gland cells carcinoma, the foremost reason
of cancer deaths in men in developed countries, representing most common malignancy in …

Layered double hydroxide modified by PEGylated hyaluronic acid as a hybrid nanocarrier for targeted drug delivery

A Dong, X Li, W Wang, S Han, J Liu, J Liu… - Transactions of Tianjin …, 2016 - Springer
In recent years, organic-inorganic hybrid nanocarriers are explored for effective drug
delivery and preferable disease treatments. In this study, using 5-fluorouracil (5-FU) as …

Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer

Y Sawada, K Omoto, N Kohei… - … Journal of Urology, 2015 - Wiley Online Library
Objectives To examine the effects of combined treatment with
sulfoquinovosylacylpropanediol and X‐ray irradiation on the remodeling of the prostate …

[PDF][PDF] Boron Neutron Capture Therapy of Cancer as a Part of Modern Nanomedicine

AV Safronov - Int J Med Nano Res, 2014 - researchgate.net
Boron neutron capture therapy (BNCT) is a method of cancer therapy with a simple idea
behind it. Positioning a certain amount of 10B-enriched boron-containing compounds into …